Iverhope 6mg Tablet DT contains Ivermectin 6mg as its active ingredient and is primarily indicated for the treatment of various parasitic infections. Ivermectin is a broad-spectrum antiparasitic agent effective against a range of internal and external parasites including strongyloidiasis, onchocerciasis, and other nematode infestations. The tablet is designed as a dispersible tablet (DT) to facilitate ease of administration, allowing rapid disintegration in the oral cavity without the need for water, which is particularly beneficial for patients with swallowing difficulties. Ivermectin acts by binding selectively to glutamate-gated chloride ion channels present in the nerve and muscle cells of parasites, leading to increased permeability to chloride ions, hyperpolarization, paralysis, and eventual death of the parasite. Iverhope 6mg Tablet DT should be administered as per the prescribed dosage regimen, typically as a single dose or repeated doses depending on the infection type and severity. It is contraindicated in patients with known hypersensitivity to ivermectin or any of the tablet excipients. Caution is advised in patients with hepatic impairment or concomitant use of other neurotoxic drugs. Common adverse effects may include dizziness, pruritus, nausea, and mild gastrointestinal disturbances. Proper medical consultation is essential before initiating therapy with Iverhope 6mg Tablet DT.